467 related articles for article (PubMed ID: 24513420)
21. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
Lee JS; Yang J; Stockl KM; Lew H; Solow BK
J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
23. Pharmacist-provided medication therapy management (part 2): Payer perspectives in 2007.
Schommer JC; Planas LG; Johnson KA; Doucette WR
J Am Pharm Assoc (2003); 2008; 48(4):478-86. PubMed ID: 18647710
[TBL] [Abstract][Full Text] [Related]
24. Perceptions of Medicare Part D enrollees about pharmacists and their role as providers of medication therapy management.
Law AV; Okamoto MP; Brock K
J Am Pharm Assoc (2003); 2008; 48(5):648-53. PubMed ID: 18826904
[TBL] [Abstract][Full Text] [Related]
25. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan.
Wittayanukorn S; Westrick SC; Hansen RA; Billor N; Braxton-Lloyd K; Fox BI; Garza KB
J Manag Care Pharm; 2013 Jun; 19(5):385-95. PubMed ID: 23697476
[TBL] [Abstract][Full Text] [Related]
27. Findings from a National Survey of Medicare Beneficiary Perspectives on the Medicare Part D Medication Therapy Management Standardized Format.
Brandt NJ; Cooke CE; Sharma K; Chou J; Carden MJ; Kumbera P; Pellegrin K
J Manag Care Spec Pharm; 2019 Mar; 25(3):366-391. PubMed ID: 30816816
[TBL] [Abstract][Full Text] [Related]
28. Patients' needs and interests in a self-pay medication therapy management service.
Friedrich M; Zgarrick D; Masood A; Montuoro J
J Am Pharm Assoc (2003); 2010; 50(1):72-7. PubMed ID: 20097642
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
30. Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007.
Schommer JC; Planas LG; Johnson KA; Doucette WR
J Am Pharm Assoc (2003); 2008; 48(3):354-63. PubMed ID: 18623906
[TBL] [Abstract][Full Text] [Related]
31. An overview and study of beneficiaries' knowledge, attitudes, and perceptions of the medicare part d benefit.
Woelfel JA; Patel RA; Lee H; Chu S; Ranson C; Patel B; Italia U; Walberg MP; Carr-Lopez SM; Galal SM
Consult Pharm; 2015 Feb; 30(2):101-11. PubMed ID: 25695416
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of a Clinical Pharmacist Medication Therapy Management Program in Discontinuation of Drugs to Avoid in the Elderly.
Caffiero N; Delate T; Ehizuelen MD; Vogel K
J Manag Care Spec Pharm; 2017 May; 23(5):525-531. PubMed ID: 28448783
[TBL] [Abstract][Full Text] [Related]
33. Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries.
Tsang CCS; Shih YT; Dong X; Garuccio J; Browning JA; Wan JY; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Zeng R; Wang J
Value Health; 2023 May; 26(5):649-657. PubMed ID: 36376143
[TBL] [Abstract][Full Text] [Related]
34. Assessing quality of life in an ambulatory medicare population.
Woelfel JA; Patel RA; Huey T; Patel U; Walberg MP; Galal SM; Carr-Lopez SM
Consult Pharm; 2012 Oct; 27(10):719-28. PubMed ID: 23045329
[TBL] [Abstract][Full Text] [Related]
35. Patients' attitude and willingness to pay for pharmaceutical care: An international message from a developing country.
Jaber D; Aburuz S; Hammad EA; El-Refae H; Basheti IA
Res Social Adm Pharm; 2019 Sep; 15(9):1177-1182. PubMed ID: 30337178
[TBL] [Abstract][Full Text] [Related]
36. Strategies for community-based medication management services in value-based health plans.
Smith MA; Spiggle S; McConnell B
Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
[TBL] [Abstract][Full Text] [Related]
37. Use of 2015 Beers Criteria Medications by Older Medicare Beneficiaries.
Patel R; Zhu L; Sohal D; Lenkova E; Koshki N; Woelfel J; Ranson C; Valle-Oseguera CS; Rogan EL
Consult Pharm; 2018 Jan; 33(1):48-54. PubMed ID: 29336278
[TBL] [Abstract][Full Text] [Related]
38. Impact on drug cost and use of Medicare part D of medication therapy management services delivered in 2007.
Winston S; Lin YS
J Am Pharm Assoc (2003); 2009; 49(6):813-20. PubMed ID: 19858047
[TBL] [Abstract][Full Text] [Related]
39. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
40. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
Almodóvar AS; Nahata MC
J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
